• No results found

University of Groningen Pharmacokinetics and pharmacodynamics of intrathecal baclofen therapy Heetla, Herre Wigger

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Pharmacokinetics and pharmacodynamics of intrathecal baclofen therapy Heetla, Herre Wigger"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Pharmacokinetics and pharmacodynamics of intrathecal baclofen therapy

Heetla, Herre Wigger

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Heetla, H. W. (2018). Pharmacokinetics and pharmacodynamics of intrathecal baclofen therapy. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Pharmacokinetics and Pharmacodynamics

of Intrathecal Baclofen Therapy

(3)

Printing of the thesis was financially supported by: University of Groningen, University Medical Center Groningen (UMCG).

Colofon

Layout & cover design: Design Your Thesis, www.designyourthesis.com Printing: Ridderprint BV, www.ridderprint.nl

ISBN (printed version): 978-94-6299-857-5 ISBN (electronic version): 978-94-034-0443-1

© 2018 Herre Wigger Heetla, The Netherlands

All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means without written permission of the author and the publisher holding the copyright of the published articles.

(4)

Pharmacokinetics and Pharmacodynamics

of Intrathecal Baclofen Therapy

P R O E F S C H R I F T

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op

maandag 26 maart 2018 om 16.15 uur

door

Herre Wigger Heetla

geboren op 20 mei 1982 te Groningen

(5)

Promotores

Prof. dr. T. van Laar Prof. dr. R.J.M. Groen Prof. dr. M.J. Staal † Copromotor Dr. J.H. Proost Beoordelingscommissie Prof. dr. J.H.B. Geertzen Prof. dr. S.M. Peerdeman Prof. dr. J.M.A. van Gerven

(6)

In dankbare herinnering

Prof. dr. M.J. Staal

(7)
(8)

TABLE OF CONTENTS

Chapter 1. General introduction and outline 9 Chapter 2. Clinical relevance of pharmacological and physiological data in

intrathecal baclofen therapy

Archives of Physical Medicine and Rehabilitation (2014), 95: 2199-2206

23

Chapter 3. Incidence and management of tolerance in intrathecal baclofen therapy Spinal Cord (2009), 47: 751–756

47

Chapter 4. Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion

Spinal Cord (2010), 48: 483–486

63

Chapter 5. A pharmacokinetic–pharmacodynamic model for intrathecal baclofen in patients with severe spasticity

British Journal of Clinical Pharmacology (2015), 81:1: 101–112

75

Chapter 6. Improved gait performance in a patient with HSP after a continuous ITB test infusion and subsequent pump implantation

Archives of Physical Medicine and Rehabilitation (2015), 96: 1166-9

103

Chapter 7. The usefulness of qualitative and quantitative tests in measuring the effect of a continuous ITB test-infusion in ambulatory patients with spasticity

Submitted for publication

113

Chapter 8. Summary and discussion 127

Chapter 9. Nederlandse samenvatting 141 Appendices List of abbreviations

Dankwoord Curriculum vitae List of publications 151 153 155 157

(9)

Referenties

GERELATEERDE DOCUMENTEN

Our data show that switching from continuous to pulsatile ITB infusion stabilized or decreased the daily ITB dose in all four patients, at least during the follow-up period of 12

The aim of this study was to measure baclofen CSF concentrations and clinical effects at various intervals after the administration of four different bolus doses of ITB in

This brief report describes a continuous ITB test infusion instead of a bolus infusion, where the ITB dose is slowly increased every 24 hours, providing the patient enough time to

The aim of this pilot study is therefore to determine which qualitative and quantitative tests on the domains of spasticity, strength, ambulatory function, and the patient’s personal

Sampling data gathered from patients receiving continuous ITB therapy are needed to predict the baclofen concentration gradient after continuous infusion.. However, it is

De patiënten met tolerantie werden omgezet naar pulsatiele infusie, waarbij de dagelijkse dosis baclofen (ten tijde van continue infusie) werd verdeeld over zes bolussen,

Mijn familie en vrienden en in het bijzonder natuurlijk mijn ouders en zusje, bedankt voor jullie onvoorwaardelijke liefde en interesse, tijdens de promotie, maar ook daarbuiten. En

Conclusions: The pharmacological and physiological data on ITB can be used to support decisions in clinical practice concerning drug concentration, infusion regimens, localization